Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Leubner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Endocrinology|March 28, 2014
Sexual well-being in adult male patients with congenital adrenal hyperplasiaBogna Dudzińska, Jonas Leubner, Manfred Ventz, et al.
BMC Neurology|February 3, 2016
Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresisBenjamin Berger, Tilman Hottenrott, Jonas Leubner, et al.
Journal of Neurology|September 7, 2018
Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnosticsLam-Thanh Ly, Jakob Kreye, Betty Jurek, et al.
Frontiers in Neurology|September 11, 2024
LZTR1 loss-of-function variants associated with café au lait macules with or without frecklingSvea Horn, Teresa Neuhann, Corina Hennig, et al.
Clinical and Translational Science|July 1, 2023
Optimizing expert and patient input in pediatric trial design: Lessons learned and recommendations from a collaboration between conect4children and European Patient-CEntric ClinicAl TRial PLatformsBritt A E Dhaenens, Fenna Mahler, Hannah Batchelor, et al.
Journal of Medical Genetics|June 26, 2026
Identification of biallelic loss-of-function <i>PREP</i> variants in three individuals with syndromic intellectual disabilityErik Hertstein, Miriam Bertrand, Johannes Kopp, et al.
Annals of Neurology|March 8, 2019
N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunitNina Kerstin Wenke, Jakob Kreye, Ewa Andrzejak, et al.
Annals of Neurology|July 21, 2019
Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain functionBetty Jurek, Mariya Chayka, Jakob Kreye, et al.
Brain : a Journal of Neurology|August 21, 2016
Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesisJakob Kreye, Nina K Wenke, Mariya Chayka, et al.
Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Endocrinology|March 28, 2014
Sexual well-being in adult male patients with congenital adrenal hyperplasiaBogna Dudzińska, Jonas Leubner, Manfred Ventz, et al.
BMC Neurology|February 3, 2016
Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresisBenjamin Berger, Tilman Hottenrott, Jonas Leubner, et al.
Journal of Neurology|September 7, 2018
Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnosticsLam-Thanh Ly, Jakob Kreye, Betty Jurek, et al.
Frontiers in Neurology|September 11, 2024
LZTR1 loss-of-function variants associated with café au lait macules with or without frecklingSvea Horn, Teresa Neuhann, Corina Hennig, et al.
Clinical and Translational Science|July 1, 2023
Optimizing expert and patient input in pediatric trial design: Lessons learned and recommendations from a collaboration between conect4children and European Patient-CEntric ClinicAl TRial PLatformsBritt A E Dhaenens, Fenna Mahler, Hannah Batchelor, et al.
Journal of Medical Genetics|June 26, 2026
Identification of biallelic loss-of-function <i>PREP</i> variants in three individuals with syndromic intellectual disabilityErik Hertstein, Miriam Bertrand, Johannes Kopp, et al.
Annals of Neurology|March 8, 2019
N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunitNina Kerstin Wenke, Jakob Kreye, Ewa Andrzejak, et al.
Annals of Neurology|July 21, 2019
Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain functionBetty Jurek, Mariya Chayka, Jakob Kreye, et al.
Brain : a Journal of Neurology|August 21, 2016
Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesisJakob Kreye, Nina K Wenke, Mariya Chayka, et al.
Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Pageof 2